secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2026-02-24T23:59:59+00:00
Accession:  0001104659-26-019143
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Palvella Therapeutics reports preliminary Dec 31, 2025 cash of $55.9M
---------------------------------------------------------------------

- Preliminary unaudited cash, cash equivalents and marketable securities as of Dec 31, 2025: $55.9 million.
- Amount subject to change upon completion of financial close procedures; not audited by Ernst & Young.
- No other financial results provided; full year 2025 results pending.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000110465926019143/0001104659-26-019143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000110465926019143/tm267157d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-019143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer